Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PAMIDRONATE Cause Left ventricular hypertrophy? 16 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Left ventricular hypertrophy have been filed in association with PAMIDRONATE (Pamidronate Disodium). This represents 1.0% of all adverse event reports for PAMIDRONATE.

16
Reports of Left ventricular hypertrophy with PAMIDRONATE
1.0%
of all PAMIDRONATE reports
3
Deaths
11
Hospitalizations

How Dangerous Is Left ventricular hypertrophy From PAMIDRONATE?

Of the 16 reports, 3 (18.8%) resulted in death, 11 (68.8%) required hospitalization, and 1 (6.3%) were considered life-threatening.

Is Left ventricular hypertrophy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PAMIDRONATE. However, 16 reports have been filed with the FAERS database.

What Other Side Effects Does PAMIDRONATE Cause?

Osteonecrosis of jaw (313) Drug ineffective (180) Pain (164) Off label use (143) Pyrexia (106) Malignant neoplasm progression (103) Dyspnoea (102) Fatigue (97) Pain in jaw (97) Metastases to bone (95)

What Other Drugs Cause Left ventricular hypertrophy?

AMLODIPINE (158) CLOZAPINE (149) TACROLIMUS (135) FUROSEMIDE (128) PANTOPRAZOLE (117) BISOPROLOL (114) SACUBITRIL\VALSARTAN (105) ASPIRIN (104) ROSUVASTATIN (94) CARVEDILOL (87)

Which PAMIDRONATE Alternatives Have Lower Left ventricular hypertrophy Risk?

PAMIDRONATE vs PAMIDRONIC ACID PAMIDRONATE vs PANCRELIPASE PAMIDRONATE vs PANCRELIPASE AMYLASE\PANCRELIPASE LIPASE\PANCRELIPASE PROTEASE PAMIDRONATE vs PANCURONIUM PAMIDRONATE vs PANITUMUMAB

Related Pages

PAMIDRONATE Full Profile All Left ventricular hypertrophy Reports All Drugs Causing Left ventricular hypertrophy PAMIDRONATE Demographics